EAT
USDBrinker International Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$102.220
Kõrge
$104.640
Madal
$101.370
Maht
0.82M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
4.6B
Tööstusharu
Restoranid
Riik
United States
Kauplemisstatistika
Keskmine maht
1.50M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
JP Morgan Maintains Overweight on Brinker International, Lowers Price Target to $155
JP Morgan analyst John Ivankoe maintains Brinker International with a Overweight and lowers the price target from $175 to $155.
Citigroup Maintains Neutral on Brinker International, Lowers Price Target to $144
Citigroup analyst Jon Tower maintains Brinker International with a Neutral and lowers the price target from $156 to $144.
Barclays Maintains Equal-Weight on Brinker International, Lowers Price Target to $135
Barclays analyst Jeffrey Bernstein maintains Brinker International with a Equal-Weight and lowers the price target from $145 to $135.
Wells Fargo Maintains Overweight on Brinker International, Lowers Price Target to $160
Wells Fargo analyst Zachary Fadem maintains Brinker International with a Overweight and lowers the price target from $175 to $160.
BRINKER INTERNATIONAL REPORTS FIRST QUARTER OF FISCAL 2026 RESULTS AND REITERATES FISCAL 2026 GUIDANCE
Brinker International, Inc. (NYSE: EAT) today announced its financial results for the first quarter ended September 24, 2025. First Quarter Fiscal...
Mizuho Initiates Coverage On Brinker International with Outperform Rating, Announces Price Target of $155
Mizuho analyst Nick Setyan initiates coverage on Brinker International with a Outperform rating and announces Price Target of $155.
UBS Maintains Neutral on Brinker International, Lowers Price Target to $144
UBS analyst Dennis Geiger maintains Brinker International with a Neutral and lowers the price target from $165 to $144.
Seotud aktsiad
FTF
Franklin Limited Duration Income Trust Common Shares of Beneficial Interest
RMBS
Rambus Inc.
ORLY
O'Reilly Auto Parts
XPER
Xperi Inc.
FBIOP
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.